Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: a prospective, randomized, controlled clinical study

Authors

Institutions

Publication Details

Journal
Cancer Immunology Immunotherapy
Published
2025-11-12
DOI
https://doi.org/10.1007/s00262-025-04227-5
Primary Topic
Proteoglycans and glycosaminoglycans research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: a prospective, randomized, controlled clinical study

X. Li, Hongchuan Zhang, Shengyuan Huang, Junfeng Li et al.
Cancer Immunology Immunotherapy
Proteoglycans and glycosaminoglycans research
article

Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: a prospective, randomized, controlled clinical study

X. Li, Hongchuan Zhang, Shengyuan Huang, Junfeng Li, Guangjin Yuan
article en

Abstract

No abstract available for this paper.
Cancer Immunology ImmunotherapyVol. 74(12)
People's Hospital of Kaizhou District (CN), First People's Hospital of Chongqing (CN)
Natural Science Foundation of Chongqing, Centre Scientifique et Technique du Bâtiment
Openalex Percentile: Top 65%
Proteoglycans and glycosaminoglycans research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.